Hasegawa et al. [81] in a UUO model and Henri et al. [14] and Vieira et al. [88] in a myocardial infarction model promoted lymphangiogenesis by exogenous VEGFC, alleviated fibrosis and improved organ function, respectively. The gene discussed is VEGFC; the disease is myocardial infarction.